Fact CheckerSign in

NCT07213375RecruitingPhase 2/3

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

High Dose Dexamethasone In High-Pain Responders Undergoing Enhanced Recovery Video-Assisted Thoracoscopic Surgery Lobectomy and Segmentectomy - A Randomized Double-Blinded Controlled Trial

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

The aim is to conduct a randomized controlled trial (RCT) with a high dose arm (1mg/kg) vs a low dose (8mg in total) of steroid (Dexamethasone) given intravenous (IV) after the induction of anesthesia to "High-pain-responders" in patients undergoing VATS lobectomy/segmentectomy. The hypothesis is that a high dose of Dexamethasone can lower pain when coughing in the morning after VATS lobectomy/segmentectomy, in patients scoring as "High-pain-responders" on the Pain-Catastrophizing-Scale

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
80 (estimated)
First submitted
23 Sept 2025
Start date
1 Sept 2025
Primary completion date
31 Oct 2026
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Diseases
Lung cancer
NCT number
NCT07213375
EU CT number
2025-520891-25-00

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 80
  • From 1 Sept 2025 to the primary completion date, 31 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients undergoing systemic glucocorticoid or other immunosuppressive therapies, ex-cluding inhaled steroids.
    • Individuals with diabetes requiring insulin treatment.
    • Pregnant or breastfeeding patients.
    • Patients with known allergies to the study drug.
    • Individuals with mental disabilities that may impair their capacity to provide informed consent or compromise the validity of data collection.
    • Patients with diagnosed schizophrenia, active psychosis, bipolar disorder, or a history of ongoing treatment with antipsychotic and/or antidepressant medications.
    • Individuals with altered pain perception due to other conditions or injuries, such as spi-nal cord or brain injuries, severe polyneuropathies, or neurological disorders.
    • Regular users of opioid medications.
    • Patients requiring reoperation within the first two postoperative days.
    • Individuals undergoing conversion to a surgical procedure other than VATS lobecto-my/segmentectomy.

Who the study is looking for

  • Age ≥ 18 year
  • Able to understand written and spoken Danish language
  • PCS ≥20
  • Signed written informed consent form.
  • Patient planned to elective VATS lobectomy/segmentectomy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rigshospitalet
Coordinator of this site? Confirm its status
Copenhagen OeDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.